Saint John's Cancer Institute (formerly John Wayne Cancer Institute) at Providence

Local experts team up with the melanoma program at Saint John's for a community education event. Register now for in-person attendance, or watch virtually via ZOOM for "Together Against Melanoma," held at the RAND Corporation in Santa Monica this Saturday, October 26th, 2024. Get answers to your questions during the Q&A session. Breakfast and a light lunch are provided. Registration is required and seating is limited. Register on the Saint John's Cancer website: https://lnkd.in/gE7hfFac Our 2024 Speakers: Rick Essner, MD Professor of Surgical Oncology Co-Director, The Borstein Family Melanoma Program Saint John’s Cancer Institute Kim Margolin, MD, FACP, FASCO Medical Director, The Borstein Family Melanoma Program Saint John’s Cancer Institute Jason R. Litak, MD Dermatologist Santa Monica Dermatology Medical Group Melody Simanian, PA-C Physician Assistant, The Borstein Family Melanoma Program Saint John’s Cancer Institute Sonia Batra, MD Batra Dermatology Santa Monica, CA Rachel Beller, MS, RDN Registered Dietitian Nutritionist Beller Nutritional Institute, LLC David Savage, MD Assistant Professor Melanoma and Sarcoma Specialist University of New Mexico Debbie Churgai, MA Education Program Manager Melanoma Research Foundation Giulia Newton, MBA MRF Board Member & Patient Advocate Melanoma Research Foundation #santamonicamelanomasymposium #melanomacancer

On September 30th, 2024, the day started early, preparing for the annual breast cancer awareness lighting at the Saint John's Health Center. At the center of planning were Dr. Rebecca Crane-Okada, Program Manager of Cancer Patient Support & Willow Sage Wellness program at the Margie Petersen Breast Center, and Alston Novak, Administrative Coordinator Cancer Support Services & Margie Petersen Breast Center, who once again, delighted friends, family, and co-workers with a festive celebration with music, decorative lighting, and heartfelt stories from guest speakers. Janie Grumley, MD, FACS, opened the evening, providing perspective, inspiration, and hope, followed by Lynda Baxter, MBA, MPH, the new executive director for Providence Saint John’s Cancer Institute and the Roy and Patricia Disney Family Cancer Center (DFCC) at Providence Saint Joseph Medical Center. Care insights were provided by Jared Amerson, Chief Administrative Officer at Saint John's, reading from a letter from a thankful friend of a cancer patient, and Tiffany Grunwald, MD, FACS, Executive Medical Director of the Women's Health & Wellness Institute at Saint John's Health Center who pulled the switch to launch a month-long lighting of the health center in a hot pink. Visit the Margie Petersen Breast Center, Center of Excellence Website: https://lnkd.in/dePaW85 See more photos from this event: @mpbcbreasties: https://lnkd.in/gb5yDun6 #breastcancerawareness #margiepetersenbreastcenter #powerofpink #saintjohnscancerinstitute #saintjohnshealthcenter

Sara Rutenberg, Vice Chair of the Board of Directors at Didi Hirsch Mental Health Services, breast cancer survivor and mentor, received the Power of Pink, 2024, Ruth Weil Spirit of Hope Award. Listen to Sara and her daughter Meg share their experience at Saint John's and with Dr. Janie Grumley, and explain why mentorship is so important. This brief video was presented at Saint John's Health Center Foundation's Power of Pink event held at the Skirball Cultural Center in Los Angeles. Margie Petersen Breast Center https://lnkd.in/dePaW85 More About Janie Grumley, MD FACS https://lnkd.in/gufScMJd #sararutenberg #margiepetersenbreastcenter #powerofpink #saintjohnshealthcenter #saintjohnshealthcenterfoundation #BreastCancerAwareness

Melvin J. Silverstein, MD, FACS, pioneer of oncoplastic breast surgery, received the Power of Pink, 2024, Advocacy for Women's Health and Wellness Award. Dr. Silverstein was Dr. Donald L. Morton's first fellow who later trained doctors Janie Grumley and Crystal Fancher. Listen to Dr. Silverstein share his story and why he pursued oncology. This brief introduction was featured to hundreds of supporters at Saint John's Health Center Foundation's Power of Pink event held at the Skirball Cultural Center in Los Angeles. Dr. Janie Grumley presented the award on Sunday, September 29th, 2024. Margie Petersen Breast Center https://lnkd.in/dePaW85 More About Janie Grumley, MD FACS https://lnkd.in/gufScMJd More About Crystal Fancher, MD FACS https://lnkd.in/gQ2B2cVV #melvinsilverstein #donaldlmorton #margiepetersenbreastcenter #breastoncology #oncoplasticsurgery #powerofpink #saintjohnshealthcenter #saintjohnshealthcenterfoundation #BreastCancerAwareness

With more than 100 successful HIFU treatments (High Intensity Focused Ultrasound), Dr. Mehran Movassaghi uses the Focal One® HIFU Robotic System, providing more treatment options for prostate cancer. Focal One® HIFU uses concentrated ultrasound to destroy tumor cells, while preserving healthy surrounding tissues. Learn more at https://lnkd.in/gFYFmYGv https://lnkd.in/g-kFXYPp • Precise treatment delivery to the tumor site • Preservation of the patient’s quality of life • Possibility to perform any other treatment if needed after Focal One® treatment Contact: Dr. Mehran Movassaghi Director of Men’s Health at Providence Saint John’s Health Center https://lnkd.in/ghNvc9Cy 310-582-7333 #focalone #hifu #prostatecancertreatment

Dr. Mehran Movassaghi discusses High-Intensity Focused Ultrasound (HIFU) on the Talk With A Doc Podcast and cancer risk in a recent blog. “There’s a newer treatment for men that is revolutionizing how early-stage prostate cancer can be treated.” – Mehran Movassaghi, MD Learn more and listen to Dr. Movassaghi’s podcast, Wellness Brief: Prostate Cancer + Focal Therapy Treatments. Podcast, Talk With A Doc: Wellness Brief: Prostate Cancer + Focal Therapy Treatments https://lnkd.in/gQXZCy-A Blog, Providence: Understanding prostate cancer screening: https://lnkd.in/gNQvVksC Treatment, Videos: High Intensity Focused Ultrasound (HIFU) for Prostate Cancer https://lnkd.in/g-kFXYPp #HIFU #focalone #ProstateCancer #prostatecancertreatment #prostatecancerawareness

New Dietary Clinical Trial for Glioblastoma | Principal Investigator, Akanksha Sharma, MD, Leads DIET2TREAT Study for Newly Diagnosed Glioblastoma Patients. “If you have been diagnosed with gliobastoma within the past 2 months and have not started standard-of-care, you may qualify to participate in this new trial.” –Akanksha Sharma, MD. Learn more about the DIET2TREAT Study and download the PDF flyer: NEWS: https://lnkd.in/gc8YB8_n #glioblastoma #pacificneuroscienceinstitute #saintjohnscancerinstitute #DIET2TREAT

The Borstein Family Melanoma Program at Saint John’s Cancer Institute and the Melanoma Research Foundation invite you to an in-depth discussion titled "Together Against Melanoma – A Patient and Caregiver Symposium on Research, Education, Hope, and Healing." This year’s event will be held at the RAND Corporation, a government facility located at the intersection of Main Street and Civic Center Drive in Santa Monica. Virtual attendance is also available on ZOOM. Saturday, October 26th 2024 From 8:00 AM to 1:00 PM PST Held at the RAND in Santa Monica 1776 Main Street, Santa Monica, CA 90401-3208 The event will include a complimentary breakfast, lunch, and refreshments. To join us, please visit our registration page, where you can explore this year’s lineup of speakers, their insightful topics, and details on the venue.* For in-person attendance, click here: https://lnkd.in/gE7hfFac For virtual attendance (ZOOM), click here: https://lnkd.in/gTMhW66z For additional information regarding attendee requirements at RAND Corporation, click here: https://lnkd.in/g3cbX5BA *Speakers and topics may change. Please check our registration page for details. A government-issued ID is required upon entry to RAND for in-person attendance. Program Directors: Richard Essner, MD, FACS Professor of Surgical Oncology Co-Director, The Borstein Family Melanoma Program Saint John’s Cancer Institute Kim Margolin, MD, FACP, FASCO Medical Director, The Borstein Family Melanoma Program Saint John’s Cancer Institute #melanomaawareness @melanomasymposium #saintjohnscancerinstitute #melanomaresearchfoundation

Fellows of The Donald L. Morton Complex General Surgical Oncology Fellowship, Breast Surgical Oncology Fellowship, Urologic Oncology Fellowship, and Neurosurgical Oncology Fellowship celebrate among mentors, peers, and supporters at their 2024 graduation ceremony. “Our fellows are leading cancer programs nationally and presenting all over the world.” - Dr. Ora Gordon. Learn more on our blog and watch the full-length program sponsored by the Saint John’s Health Center Foundation. Blog: https://lnkd.in/gBR_Sgd4 #saintjohnscancerinstitute #saintjohnshealthcenterfoundation #pacificneuroscienceinstitute #surgicaloncology

Galleri Multi-Cancer Early Detection (MCED) Test Discovers Stage 2 Pancreatic Cancer | Dr. Ora Gordon, co-principal investigator of the study, speaks with Harris Bass at Saint John’s Health Center after his surgery performed by Dr. Anton Bilchik. “I would tell anybody to come here.” – Harris Bass Learn more about how Harris discovered he had pancreatic cancer and what led him to Saint John’s: SJCI Blog: <https://lnkd.in/gwpT6PGc> Learn more about MCED (Multi-Cancer Early Detection), which can detect up to 50 different types of cancer in a single blood draw: SJCI Blog: <https://lnkd.in/giFbituF> Interview Correction: When there is a positive result for the Galleri test, the chance that the result is truly positive is called positive predictive value (PPV) and is approximately 43%. The statistic of 99.5% describes the Galleri test’s specificity, or the ability of the test to identify people who do not have cancer. #pancreaticcancer #clinicaltrials #saintjohnscancerinstitute #cancerresearch #cancerscreening #cancertreatment #earlydetection #galleri #MCED